开盘价:-- | 最高价:-- | 最低价:-- | 52周最高价:-- | 52周最低价:-- |
成交量:-- | 平均成交量:-- | 市值:-- | 市盈率:-- | 预期市盈率:-- |
每股收益:-- | 贝塔系数:-- | 股息:-- | 收益率:-- | 总股本:-- |
证券代码:aptx | 公司名称:Aptinyx, Inc. | 公司中文简称: |
公司简介: Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL. |
||
公司网站: http://www.aptinyx.com |
||
公司地址: 909 Davis Street Suite 600 Evanston |